Positive News SentimentPositive NewsNASDAQ:PRVA Privia Health Group (PRVA) Stock Price, News & Analysis → Strange new buyer driving up gold (From Stansberry Research) (Ad) Free PRVA Stock Alerts $18.03 +0.21 (+1.18%) (As of 03:27 PM ET) Add Compare Share Share Today's Range$17.74▼$18.1450-Day Range$17.69▼$22.9252-Week Range$17.54▼$30.15Volume512,204 shsAverage Volume955,414 shsMarket Capitalization$2.14 billionP/E Ratio94.90Dividend YieldN/APrice Target$28.18 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Privia Health Group alerts: Email Address Privia Health Group MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside56.3% Upside$28.18 Price TargetShort InterestHealthy6.58% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$299,061 Sold Last QuarterProj. Earnings Growth30.77%From $0.26 to $0.34 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.55 out of 5 starsMedical Sector79th out of 918 stocksHealth Services Industry1st out of 10 stocks 4.4 Analyst's Opinion Consensus RatingPrivia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoveragePrivia Health Group has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted6.58% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 6.8.Change versus previous monthShort interest in Privia Health Group has recently decreased by 8.22%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRVA. Previous Next 2.7 News and Social Media Coverage News SentimentPrivia Health Group has a news sentiment score of 1.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Privia Health Group this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for PRVA on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $299,061.00 in company stock.Percentage Held by Insiders14.20% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Privia Health Group are expected to grow by 30.77% in the coming year, from $0.26 to $0.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 94.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.49.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 94.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 207.50.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 2.44. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchStrange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."But there's a much better move you can make to get in front of these big moves today. About Privia Health Group Stock (NASDAQ:PRVA)Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Read More PRVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRVA Stock News HeadlinesApril 5, 2024 | insidertrades.comInsider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) CFO Sells 3,933 Shares of StockApril 9, 2024 | globenewswire.comPrivia Health to Report First Quarter 2024 Results on Thursday, May 9April 19, 2024 | Stansberry Research (Ad)Strange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."April 4, 2024 | finance.yahoo.comPRVA: Rating increased to a HOLDMarch 19, 2024 | markets.businessinsider.comAnalyst Scoreboard: 8 Ratings For Privia Health GrMarch 6, 2024 | markets.businessinsider.comJP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To KnowMarch 1, 2024 | markets.businessinsider.comPrivia Health Group’s Strong Q4 Performance and Strategic Focus Earns Buy RatingFebruary 29, 2024 | seekingalpha.comPrivia Health Group, Inc. (PRVA) Q4 2023 Earnings Call TranscriptApril 19, 2024 | Stansberry Research (Ad)Strange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."February 29, 2024 | markets.businessinsider.comForecasting The Future: 4 Analyst Projections For Privia Health GrFebruary 29, 2024 | finance.yahoo.comPrivia Health Group, Inc. Just Missed Earnings - But Analysts Have Updated Their ModelsFebruary 28, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Privia Health Group (PRVA)February 28, 2024 | finance.yahoo.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q4 2023 Earnings Call TranscriptFebruary 27, 2024 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 27, 2024 | markets.businessinsider.comPrivia Health Q4 Profit Down, But Beats Estimates; Sees Annual Revenue Below View - UpdateFebruary 27, 2024 | finance.yahoo.comPrivia Health Group Inc (PRVA) Reports Strong Full-Year 2023 Financial ResultsFebruary 27, 2024 | seekingalpha.comPrivia Health Group, Inc. 2023 Q4 - Results - Earnings Call PresentationFebruary 27, 2024 | globenewswire.comPrivia Health Reports Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 26, 2024 | benzinga.comPrivia Health Gr's Earnings: A PreviewFebruary 23, 2024 | investing.comPrivia Health Group Inc (PRVA)February 22, 2024 | msn.comB of A Securities Downgrades Privia Health Group (PRVA)February 22, 2024 | markets.businessinsider.comB of A Securities Downgrades Privia Health Gr: Here's What You Need To KnowFebruary 21, 2024 | finance.yahoo.comPrivia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The BusinessFebruary 17, 2024 | finance.yahoo.comPRVA Mar 2024 25.000 callFebruary 16, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Privia Health Group (PRVA)February 14, 2024 | barrons.comPrivia Health Group Inc.January 31, 2024 | markets.businessinsider.comMaintaining Buy Rating on Privia Health Group Amidst VBC Contract Loss in CaliforniaSee More Headlines Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today4/19/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:PRVA CUSIPN/A CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees1,102Year FoundedN/APrice Target and Rating Average Stock Price Target$28.18 High Stock Price Target$40.00 Low Stock Price Target$21.00 Potential Upside/Downside+56.3%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.19 Trailing P/E Ratio94.90 Forward P/E Ratio69.35 P/E Growth2.44Net Income$23.08 million Net Margins1.39% Pretax Margin1.75% Return on Equity3.97% Return on Assets2.43% Debt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.81 Sales & Book Value Annual Sales$1.66 billion Price / Sales1.29 Cash Flow$0.25 per share Price / Cash Flow71.17 Book Value$5.14 per share Price / Book3.51Miscellaneous Outstanding Shares118,660,000Free Float101,807,000Market Cap$2.14 billion OptionableOptionable Beta0.81 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Parth Mehrotra (Age 45)CEO & Director Comp: $1.19MMr. David Mountcastle CPA (Age 54)MBA, Executive VP, CFO & Principal Accounting Officer Comp: $713.72kMr. Thomas Bartrum (Age 56)Executive Officer Comp: $533.02kMr. Chris VoigtExecutive VP & Chief Technology OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate CommunicationsMs. Dana Fields CPASenior VP of Internal Audit & Chief Compliance OfficerMr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate SecretaryMs. Jenny HardingChief People OfficerMr. Jay StevensSenior VP & Chief Growth OfficerMr. Eric J. BeyerExecutive Vice President of Medical GroupsMore ExecutivesKey CompetitorsLifeStance Health GroupNASDAQ:LFSTMagellan HealthNASDAQ:MGLNU.S. Physical TherapyNYSE:USPHPhreesiaNYSE:PHRAlignment HealthcareNASDAQ:ALHCView All CompetitorsInsiders & InstitutionsState of Alaska Department of RevenueSold 649 shares on 4/19/2024Ownership: 0.053%Allspring Global Investments Holdings LLCBought 756 shares on 4/18/2024Ownership: 0.008%Park Place Capital CorpBought 1,335 shares on 4/18/2024Ownership: 0.002%Guidance Capital Inc.Bought 21,125 shares on 4/17/2024Ownership: 0.018%Los Angeles Capital Management LLCSold 2,484 shares on 4/5/2024Ownership: 0.032%View All Insider TransactionsView All Institutional Transactions PRVA Stock Analysis - Frequently Asked Questions Should I buy or sell Privia Health Group stock right now? 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PRVA shares. View PRVA analyst ratings or view top-rated stocks. What is Privia Health Group's stock price target for 2024? 10 Wall Street analysts have issued 12-month target prices for Privia Health Group's shares. Their PRVA share price targets range from $21.00 to $40.00. On average, they predict the company's share price to reach $28.18 in the next year. This suggests a possible upside of 56.3% from the stock's current price. View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts. How have PRVA shares performed in 2024? Privia Health Group's stock was trading at $23.03 on January 1st, 2024. Since then, PRVA shares have decreased by 21.7% and is now trading at $18.03. View the best growth stocks for 2024 here. When is Privia Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our PRVA earnings forecast. How can I listen to Privia Health Group's earnings call? Privia Health Group will be holding an earnings conference call on Thursday, May 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) released its earnings results on Tuesday, February, 27th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.02. The business had revenue of $440.80 million for the quarter, compared to the consensus estimate of $425.81 million. Privia Health Group had a net margin of 1.39% and a trailing twelve-month return on equity of 3.97%. The business's quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.14 earnings per share. What ETFs hold Privia Health Group's stock? ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), ROBO Global Healthcare Technology and Innovation ETF (HTEC), BNY Mellon Innovators ETF (BKIV), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Disruptive Medicine ETF (FMED) and Franklin Genomic Advancements ETF (HELX). What guidance has Privia Health Group issued on next quarter's earnings? Privia Health Group issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.9 billion. When did Privia Health Group IPO? Privia Health Group (PRVA) raised $351 million in an initial public offering on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are Privia Health Group's major shareholders? Privia Health Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.05%), Los Angeles Capital Management LLC (0.03%), Guidance Capital Inc. (0.02%), Allspring Global Investments Holdings LLC (0.01%) and Park Place Capital Corp (0.00%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRVA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm PressHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.